![EMJ Oncology 10 [Supplement 4] 2022 Feature Image](https://www.emjreviews.com/wp-content/uploads/2022/02/EMJ-Oncology-10-Supplement-4-2022-Feature-Image-610x366.jpg)
7 Mins
24 Feb 2022
Evolving the Role for Immunotherapy in Lung Cancer: Extensive-Stage Small Cell Lung Cancer and Unresectable Stage III Non-small Cell Lung Cancer
Lung cancer is classified into NSCLC (85% of patients) and SCLC (15%). NSCLC can be further classified histologically into three main type…

11 Mins
18 Feb 2022
New Developments, Data, and Guideline Updates: Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism Associated with Cancer – Interviews with Key Opinion Leaders
CAT is a serious complication that can affect up to 6% of patients with cancer, and is associated with a 2–5-fold increased risk of…
Loading posts...